{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nVasoactive intestinal peptide (VIP) plays a critical role in circadian and mood regulation. Genetic studies have implicated VIP‐related genes in the susceptibility to bipolar disorder, whereas quantitative analyses of the suprachiasmatic nucleus demonstrate that the number of VIP‐expressing neurons correlates with circadian amplitude and may be altered in neurodegenerative conditions such as Alzheimer’s disease."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nVIP exerts potent immunomodulatory and neuroprotective actions. By binding to high‐affinity VPAC receptors, VIP inhibits the production of proinflammatory mediators in microglia and macrophages through down‐regulation of the Jak/STAT1 signaling cascade. In addition, VIP reshapes T-cell responses—shifting the balance away from Th1/Th17 profiles toward Th2 and regulatory phenotypes—and thereby reduces neuroinflammation, supporting its therapeutic potential in conditions such as rheumatoid arthritis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "7"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nWithin neural circuits, VIP-expressing interneurons contribute to disinhibition of cortical networks. In the neocortex, they inhibit neighboring somatostatin-positive inhibitory neurons, effectively creating transient “spotlights” of activity that permit selective propagation of excitatory signals and may underlie mechanisms of attention and sensory processing."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nVIP’s roles extend to the gastrointestinal tract where it is involved in both antimicrobial defense and barrier regulation. VIP exhibits antimicrobial activity against a variety of pathogens and modulates epithelial permeability—findings that are relevant to the pathophysiology of disorders such as irritable bowel syndrome. Moreover, aberrant VIP secretion in neuroblastic tumors is associated with syndromes manifesting as watery diarrhea."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "11"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of cancer and cell differentiation, VIP influences several signaling pathways that regulate angiogenesis, survival, and differentiation. In breast and prostate cancers, VIP drives upregulation of vascular endothelial growth factor and activates downstream anti-apoptotic mechanisms. Furthermore, studies in neuroblastoma highlight how VIP, through distinct receptor splice variants, can modulate cellular differentiation via both genomic and non-genomic pathways, emphasizing its multifaceted role in tumor biology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "16"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nVIP also contributes to autonomic and endocrine regulation. It is robustly expressed in parasympathetic ganglia such as the sphenopalatine ganglion, where it modulates cranial outflow, and it influences adrenal cortical function by enhancing aldosterone secretion. In addition, VIP affects other peripheral systems including hematopoietic progenitor regulation and tissue repair processes, as suggested by its localization in structures like the pseudocapsule of uterine fibroids and its potential involvement in joint homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "21"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, alterations in VIP levels are emerging as clinically relevant biomarkers. For example, serum VIP concentrations have been correlated with disease severity and therapeutic outcomes in early arthritis, underscoring the peptide’s translational potential in various inflammatory and autoimmune disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nStructural studies of VIP and its interactions with VPAC receptors further illuminate its high potency and complex mode of action. Detailed characterization of receptor binding sites and splice variant profiles confirms that variations in receptor structure profoundly influence VIP-mediated signaling, thereby modulating its effects in neurodevelopment, tumorigenesis, and immune regulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Virginia Soria, Erika Martínez-Amorós, Geòrgia Escaramís, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/npp.2009.230"}], "href": "https://doi.org/10.1038/npp.2009.230"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20072116"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20072116"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Joshua L Wang, Andrew S Lim, Wei-Yin Chiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.24432"}], "href": "https://doi.org/10.1002/ana.24432"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25921596"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25921596"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "J A Waschek "}, {"type": "b", "children": [{"type": "t", "text": "VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Pharmacol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/bph.12181"}], "href": "https://doi.org/10.1111/bph.12181"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23517078"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23517078"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Mario Delgado "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M303199200"}], "href": "https://doi.org/10.1074/jbc.M303199200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12754213"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12754213"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Elena Gonzalez-Rey, Nieves Varela, Alejo Chorny, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Pharm Des (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/138161207780618966"}], "href": "https://doi.org/10.2174/138161207780618966"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17430175"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17430175"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Raúl Villanueva-Romero, Irene Gutiérrez-Cañas, Mar Carrión, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Anti-Inflammatory Mediator, Vasoactive Intestinal Peptide, Modulates the Differentiation and Function of Th Subsets in Rheumatoid Arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2018/6043710"}], "href": "https://doi.org/10.1155/2018/6043710"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30155495"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30155495"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Rebeca Jimeno, Javier Leceta, Marina Garín, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Th17 polarization of memory Th cells in early arthritis: the vasoactive intestinal peptide effect."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Leukoc Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1189/jlb.3A0714-327R"}], "href": "https://doi.org/10.1189/jlb.3A0714-327R"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25957307"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25957307"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Mahesh M Karnani, Jesse Jackson, Inbal Ayzenshtat, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Opening Holes in the Blanket of Inhibition: Localized Lateral Disinhibition by VIP Interneurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.3646-15.2016"}], "href": "https://doi.org/10.1523/JNEUROSCI.3646-15.2016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27013676"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27013676"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ikhlas A El Karim, Gerard J Linden, David F Orr, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neuroimmunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jneuroim.2008.05.014"}], "href": "https://doi.org/10.1016/j.jneuroim.2008.05.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18603306"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18603306"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Olga Bednarska, Susanna A Walter, Maite Casado-Bedmar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2017.06.051"}], "href": "https://doi.org/10.1053/j.gastro.2017.06.051"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28711627"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28711627"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Franck Bourdeaut, Emilie de Carli, Sandra Timsit, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l'Enfant (SFCE)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatr Blood Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pbc.21912"}], "href": "https://doi.org/10.1002/pbc.21912"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19143025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19143025"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "E M Lutz, E Ronaldson, P Shaw, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Neurosci (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mcn.2005.09.008"}], "href": "https://doi.org/10.1016/j.mcn.2005.09.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16226889"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16226889"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Beatriz Collado, Irene Gutiérrez-Cañas, Nieves Rodríguez-Henche, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Regul Pept (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.regpep.2004.01.013"}], "href": "https://doi.org/10.1016/j.regpep.2004.01.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15093699"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15093699"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Konduru S R Sastry, Adrienne Joy Smith, Yelena Karpova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M602928200"}], "href": "https://doi.org/10.1074/jbc.M602928200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16728406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16728406"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Andrew E L Tee, Glenn M Marshall, Pei Y Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.053041"}], "href": "https://doi.org/10.1074/jbc.M109.053041"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20007697"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20007697"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Grazia Maugeri, Agata Grazia D'Amico, Daniela Maria Rasà, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PACAP and VIP regulate hypoxia-inducible factors in neuroblastoma cells exposed to hypoxia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropeptides (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.npep.2018.04.009"}], "href": "https://doi.org/10.1016/j.npep.2018.04.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29699729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29699729"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "A Csati, J Tajti, A Kuris, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroscience (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuroscience.2011.10.055"}], "href": "https://doi.org/10.1016/j.neuroscience.2011.10.055"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22108610"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22108610"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Maria Teresa Conconi, Raffaella Spinazzi, Gastone G Nussdorfer "}, {"type": "b", "children": [{"type": "t", "text": "Endogenous ligands of PACAP/VIP receptors in the autocrine-paracrine regulation of the adrenal gland."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Rev Cytol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0074-7696(06)49001-X"}], "href": "https://doi.org/10.1016/S0074-7696(06"}, {"type": "t", "text": "49001-X) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16697281"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16697281"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Pranela Rameshwar, Pedro Gascon, Hyun S Oh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Hematol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0301-472x(02)00875-5"}], "href": "https://doi.org/10.1016/s0301-472x(02"}, {"type": "t", "text": "00875-5) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12225791"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12225791"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Antonio Malvasi, Andrea Tinelli, Carlo Cavallotti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distribution of substance P (SP) and vasoactive intestinal peptide (VIP) in pseudocapsules of uterine fibroids."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2010.10.034"}], "href": "https://doi.org/10.1016/j.peptides.2010.10.034"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21167238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21167238"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Wei Jiang, Shu-guang Gao, Xia-guang Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of synovial fluid and articular cartilage VIP in human osteoarthritic knee: a new indicator of disease severity?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Biochem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.clinbiochem.2012.08.020"}], "href": "https://doi.org/10.1016/j.clinbiochem.2012.08.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22959974"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22959974"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Carmen Martínez, Ana M Ortiz, Yasmina Juarranz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum levels of vasoactive intestinal peptide as a prognostic marker in early arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0085248"}], "href": "https://doi.org/10.1371/journal.pone.0085248"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24409325"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24409325"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Emilie Ceraudo, Samuel Murail, Yossan-Var Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2007-0361"}], "href": "https://doi.org/10.1210/me.2007-0361"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17885205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17885205"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Joanna M Hill "}, {"type": "b", "children": [{"type": "t", "text": "Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Pharm Des (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/138161207780618975"}], "href": "https://doi.org/10.2174/138161207780618975"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17430171"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17430171"}]}]}]}